Jinyu Bio-Technology Hits Day Low of CNY 11.82 Amid Price Pressure

Jinyu Bio-Technology Co., Ltd. has experienced a notable decline today, with the stock dropping by 3.88% as it reached an intraday low of CNY 11.82. This performance contrasts sharply with the China Shanghai Composite, which has seen a modest gain of 0.4% on the same day. Over the past week, Jinyu's stock has decreased by 1.33%, while its performance over the last month shows a significant decline of 20.67%. Despite a strong annual return of 55.76%, the year-to-date performance reflects a downturn of 21.04%. The company has faced challenges in profitability, evidenced by a low Return on Capital Employed (ROCE) of 6.64% and a Return on Equity (ROE) of just 0.68%. Additionally, Jinyu has reported negative results for the last four consecutive quarters, with operating cash flow at its lowest point of CNY 303.08 million. The stock's high Price to Book ratio of 2.43 and a dividend yield of 0.25% further highlight the company's current financial landscape. As Jinyu navigates these challenges, its market position within the pharmaceuticals and biotechnology sector remains under scrutiny.